Tango Therapeutics, Inc. (TNGX)

CIK 1819133 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Tango Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Sep 3, 202640001193125-26-381853
Aug 14, 2026SCHEDULE 13G0000886982-26-000510
Aug 14, 2026SCHEDULE 13G/A0001193125-26-352271
Aug 14, 2026SCHEDULE 13G/A0000919574-26-005265
Aug 14, 2026SCHEDULE 13G/A0001916761-26-000008
Aug 14, 2026SCHEDULE 13G/A0000908834-26-000425
Aug 12, 2026SCHEDULE 13G/A0000919574-26-004954
Aug 11, 20268-K0001193125-26-344997
Aug 11, 20268-K0001193125-26-343434
Aug 11, 202610-Q0001193125-26-343424
Aug 11, 2026424B50001193125-26-344989
Aug 7, 20268-K/A0001193125-26-339070
Aug 6, 20268-K0001193125-26-338480
Aug 5, 202640001193125-26-335002
Aug 3, 20261440001950047-26-007562
Jul 2, 202640001193125-26-295124
Jun 23, 202630001193125-26-279866
Jun 23, 202640001193125-26-279871
Jun 23, 20268-K0001193125-26-279788
Jun 17, 20261440001894038-26-000002
Jun 11, 20261440001950047-26-005968
Jun 10, 2026424B50001193125-26-266074
Jun 10, 20261440001950047-26-005901
Jun 10, 20268-K0001193125-26-266078
Jun 10, 2026FWP0001193125-26-264555